Navigation Links
Halozyme Therapeutics Begins Phase 1 Clinical Trial of Bisphosphonate Administered With rHuPH20 Enzyme
Date:12/10/2008

SAN DIEGO, Dec. 10 /PRNewswire-FirstCall/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology, and drug delivery markets, today announced the commencement of patient dosing for a Phase 1 clinical trial for a bisphosphonate administered with Halozyme's recombinant human hyaluronidase enzyme (rHuPH20) as a subcutaneous (SC) injection. This study will explore the safety, tolerability and pharmacokinetics of SC administration of a bisphosphonate plus rHuPH20. Currently, injectable bisphosphonates must be administered intravenously (IV).

"We are pleased that the first clinical trial is underway for our bisphosphonate program, our third proprietary product development initiative to enter clinical studies," stated Jonathan Lim, M.D., President and CEO of Halozyme Therapeutics. "The bisphosphonate program joins insulin, for diabetes, and Chemophase, for superficial bladder cancer, our other two proprietary programs in clinical development. The goal of Halozyme's bisphosphonate program is to provide an alternative dosage formulation that may offer greater convenience, compliance and tolerability to patients for the treatment of osteoporosis."

This Phase 1 dose ranging clinical trial will assess the safety, tolerability and pharmacokinetics of a bisphosphonate with and without co-administration of rHuPH20 across a range of bisphosphonate concentrations and volumes and various rHuPH20 doses. The study will also compare SC administration of a bisphosphonate plus rHuPH20 to IV bisphosphonate alone.

About Halozyme Therapeutics, Inc.

Halozyme is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for t
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
2. Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
3. Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial
4. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
5. Halozyme Therapeutics Presents Findings on Combinations of rHuPH20 Enzyme With Bisphosphonates at the American Association for Cancer Research Conference
6. Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
7. Halozyme Therapeutics Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex
8. Halozyme Therapeutics Completes Enrollment in Chemophase Phase I/IIa Clinical Trial for Superficial Bladder Cancer
9. Orexigen(R) Therapeutics Announces Changes to Its Clinical Programs and Management Team
10. TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia
11. Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... JANESVILLE, Wis. , Nov. 27, 2014  Javon ... - On November 19, faculty and staff at Janesville ... casualty care training from Mercy Health System physicians and ... Janesville Fire Departments and the ... of the Casualty Care Program, dedicated to providing schools ...
(Date:11/27/2014)... 2014 - New Solution That ... JIN Co., Ltd. will launch JINS MEME "ACADEMIC ... 500,000 yen or $5,000 (without tax /including two pairs of ... is a dedicated solution of "JINS MEME" to academic researchers, ... data* generated by electrooculography and six-axis sensors without API. (*Physiological ...
(Date:11/26/2014)... ANDOVER, Mass. , Nov. 26, 2014 /PRNewswire/ ... AEX: PHIA) today announced expanded availability of ... including DuraDiagnost, DigitalDiagnost, MobileDiagnost wDR, MobileDiagnost Opta[i] , ... of these solutions now available in the U.S., ... global markets, the portfolio offers Philips, customers innovative ...
Breaking Medicine Technology:Mercy Health System, Janesville Police / Fire, provide casualty training to high school faculty 2Mercy Health System, Janesville Police / Fire, provide casualty training to high school faculty 3JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 2JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 3Philips expands global reach of diagnostic X-Ray solutions 2Philips expands global reach of diagnostic X-Ray solutions 3
... March 29, 2011 Royal DSM, the global ... the Ambassador of the Kingdom of the Netherlands to ... North Carolina facilities on March 28, 2011. Ambassador Jones-Bos ... and Dyneema-Ultra-High Molecular Weight Polyethylene fiber operations, and toured ...
... 2011 Diopsys, Inc. has launched the new Diopsys® ... ophthalmologists detect optic nerve disease, including glaucoma and other ... leading cause of blindness in the world, reports the ... is often called the "sneak thief of sight" because ...
Cached Medicine Technology:Dutch Ambassador Visits DSM in North Carolina 2Dutch Ambassador Visits DSM in North Carolina 3New Vision Test Helps Detect Optic Nerve Diseases Including Glaucoma 2
(Date:11/28/2014)... -- Planning on seconds at Thanksgiving Day dinner this ... as gastroesophageal reflux disease (GERD) -- a few steps may ... nose and throat specialist at Lenox Hill Hospital in New ... on Thanksgiving: Pace yourself. Rather than ... throughout the day. It,s also a good idea to have ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Not only ... create products free of petroleum, parabens and other cancer-causing ... that fund research, education and awareness programs that help ... staff and owners have raised an incredible, record-breaking contribution ... the Cure, sales of the Sweet Red Rose Whip ...
(Date:11/28/2014)... An inventor and dental assistant from Kent, Wash., was using ... was almost impossible to reach. "This gave me the idea ... patent-pending Access Light allows for easier use of a dental ... as well as avoids harm to the lips, tongue and ... clean, it also helps prevent cross-contamination. , The original design ...
(Date:11/28/2014)... Canada (PRWEB) November 28, 2014 ... the stuff kids lose® and an award-winning company established ... Julie Ellis, Cynthia Esp, and Tricia Mumby have been ... They were recognized with the PROFIT Award for Excellence ... Ellis, Cynthia Esp, and Tricia Mumby) accepted the award ...
(Date:11/28/2014)... 28, 2014 A newly released article ... overview of the influenza virus that will soon be spreading ... , The article begins with a brief explanation of what ... It reminds families that children under the age of 5, ... chronic diseases, such as heart and lung diseases, asthma, or ...
Breaking Medicine News(10 mins):Health News:Don't Let Chronic Heartburn Spoil Your Thanksgiving Feast 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 2Health News:Éminence Organic Skin Care Donates Record-breaking $30,000 to Breast Cancer Research 3Health News:Mabel's Labels’ Co-Founders Named A Winner In The 2014 RBC Canadian Women Entrepreneur Awards Program; A Second-Time Win For The Brand 2Health News:Mabel's Labels’ Co-Founders Named A Winner In The 2014 RBC Canadian Women Entrepreneur Awards Program; A Second-Time Win For The Brand 3Health News:How Flu Vaccines Can Impact Families Is Discussed in New Article from Community Health Center of Snohomish County 2
... SATURDAY, March 17 (HealthDay News) -- People who follow ... to die than those who follow few or none ... nearly 45,000 U.S. adults. However, the researchers also ... behavior recommended by the American Heart Association (AHA), which ...
... SATURDAY, March 17 (HealthDay News) -- Teens and young adults ... time may be risking brain damage, an expert warns. ... four alcoholic drinks by males and three drinks by females ... or addiction, said Dr. Alicia Ann Kowalchuk, medical director of ...
... (HealthDay News) -- Deaf people are about twice as likely ... population, according to a new review of evidence. In ... and the quality of care tends to be lower, according ... Lancet . The researchers also found that deaf children ...
... -- Obesity appears to significantly increase the risk of ... of mortality even among those prescribed 18 or fewer ... emerged as a marker of increased vulnerability," said Robert ... Epidemiology and Prevention | Nutrition, Physical Activity and Metabolism ...
... assisted reproduction are no longer experimental procedures. In some ... are conceived by IVF, and in every kindergarten classroom there ... Assisted reproduction is the solution to today,s epidemic of infertility. ... and Society by Bart Fauser and Paul Devroey (Oxford | ...
... have effective antimicrobial activity against Staphylococcus saprophyticus ... used as a protective wound-healing material to avoid opportunistic ... Chitosan is a natural, non-toxic and biodegradable, polysaccharide ... shells of shrimp, lobster and the beak of the ...
Cached Medicine News:Health News:Following Heart-Healthy Behaviors May Lengthen Your Life 2Health News:Following Heart-Healthy Behaviors May Lengthen Your Life 3Health News:Spring Break Boozing May Put Young Brains at Risk 2Health News:Deaf People Have More Mental Health Problems, Less Access to Care 2Health News:Obesity raises death risk tied to sleeping pills 2Health News:Obesity raises death risk tied to sleeping pills 3Health News:'Baby-making' 2Health News:Nano rescues skin 2
Bipolar forceps...
... Nucleic Acid Hybridization Assay with ... for the Qualitative Detection of ... and 68 and Analysis of ... in Cervical Specimens: HPV Types ...
... radiation protection-0.62mm (+/- .05)Pb lead glass equivelant ... their level of protection, they are incredibly ... on your bridge while hugging your face ... corrective lenses, you can order Leaded Eyeglasses ...
... in the world, there is a now a ... VVC in female patients. CanDia5® is a simple-to-use, ... Candida antigens almost instantaneously (within 5 minutes) with ... is no similar POC product for VVC diagnosis ...
Medicine Products: